We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Commission has approved ViiV Healthcare’s long-acting HIV treatment Vocabria (cabotegravir) for use in combination with Janssen’s Rekambys (rilpivirine) and Edurant (rilpivirine). Read More
The oral formulation “may eliminate some patients’ need to visit the clinic for treatments that require administration by a healthcare provider,” said Richard Pazdur, director of the FDA’s Oncology Center of Excellence. Read More
Vaccinations using Pfizer/BioNTech’s COVID-19 vaccine are set to begin Sunday throughout Europe, following the European Commission’s landmark authorization of its first coronavirus vaccine. Read More
Benlysta was first approved in 2011 for patients with systemic lupus erythematosus receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives and nonsteroidal anti-inflammatory drugs. Read More
The U.S. is set to begin vaccinations of healthcare workers and long-term care facility residents with the nation’s second authorized COVID-19 vaccine today, following the landmark authorization Friday of Moderna’s highly effective shot and its subsequent rollout over the weekend. Read More
Novartis believes the drug can become the first complement pathway inhibitor to slow disease progression in several complement-driven diseases. Read More